Researchers at the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute report that ...

Enables cutting-edge collaborative clinical and translational research to accelerate new radiopharmaceutical drugs to market Provides an integrated, one-stop expert resource to support all stages of ...

Funded by donations from the family of the late Samsung Chairman Lee Kun-hee, the treatment injects patients with a drug that ...

WASHINGTON, September 29, 2024 — A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering ...

Molecular Targeting Technologies, Inc. (MTTI), a clinical-stage biotechnology company developing next-generation ...

A novel radiopharmaceutical therapy approach that targets fibroblast activation protein (FAP)—which is highly expressed in many types of cancer—is safe and effective for patients, according to a new ...

Reston, VA (October 2, 2024) — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has designated nearly 100 institutions as Radiopharmaceutical Therapy Centers of Excellence across the ...

Nuclear physics, biotechnology and clinical practice have come a long way, and in the era of AI, these advances are leading to innovative solutions that are truly impacting lives. In the last two ...

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX), backed by significant analyst-implied upside, ranks among the overlooked ...

A novel radiopharmaceutical therapy approach that targets fibroblast activation protein (FAP)-which is highly expressed on many types of cancers-is safe and effective for patients, according to a new ...

Please provide your email address to receive an email when new articles are posted on . ASTRO program aims to improve access to supervised cases for ...